Tom Marjot (@tom_marjot) header
Tom Marjot (@tom_marjot) profile picture

Senior Lecturer & Consultant Hepatologist | Roger Williams Institute of Liver Studies | King's College London | Interested in #MASLD & #Circadian rhythms

London
Joined August 2020
Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)Photo by Tom Marjot (@tom_marjot)
1/🧵New in @Cell_Metabolism: Human #MASLD is a diurnal disease driven by multisystem insulin resistance & reduced insulin availability at night. The bottom line: 📢 Multiple pathways governing intrahepatic lipid accumulation are upregulated at night🌉 🔗cell.com/cell-metabolism/ful…
4
8
29
1,661
HCC surveillance: A simple, pragmatic decision ... yeah, right! 🤡 Ingredients: 1💡Hepatoepidemiologist from 🇩🇰 , where cirrhosis per se is NOT an indication 1 🇺🇸 KOL Honestly, this was the most exciting TLTM episode I moderated so far! Don't miss it #LiverTwitter 🍿
In the next #TalkLiverToMe, experts revisit the fundamentals of hepatocellular carcinoma surveillance, with a practical look at patient selection, timing and the modalities available for early detection. Tune in this Wednesday on your Spotify, Apple Podcasts or EASL Campus to listen to this interactive discussion. More information: easl.eu/event/hepatocellular…
1
4
1
16
1,613
Tom Marjot retweeted
Resmetirom and semaglutide are changing the treatment landscape for MASH, but how should they be used in practice?🤔 Tune in to #TalkLiverToMe this Wednesday for a practical discussion on treatment initiation, monitoring, and efficacy assessment, based on the 2026 EASL–EASD–EASO Guidance. Read more: easl.eu/event/resmetirom-and…
7
1
12
1,874
Tom Marjot retweeted
Why is no one talking about Africa’s liver disease burden? Tune in to #TalkLivertoMe this Wednesday for a discussion on the evolving epidemiology of liver disease across Africa, including viral hepatitis, MASLD, HCC, gaps in surveillance, and barriers to equitable care. Read more: easl.eu/event/africas-liver-…
1
3
5
925
Tom Marjot retweeted
This episode of #TalkLivertoMe explores the practical dos and don’ts of acute liver failure care, using case-based discussion to highlight what matters most in the critical early stages. Out this Wednesday! Read more: easl.eu/event/what-are-the-d…
1
6
12
1,054
Tom Marjot retweeted
From suspicion to genetic diagnosis 🔬 In the next EASL DeepDive, explore how genetic testing can support the diagnosis of #PFIC, including: 🧬 Key genetic drivers 🔎 Modern testing approaches 🩺 Positioning testing in the diagnostic pathway 🧩 Interpreting findings in the clinical context 📅 Wednesday 9 September 2026 at 18:00 CEST 🔗 easl-eu.zoom.us/webinar/regi…
5
11
958
Tom Marjot retweeted
Endohepatology promises a more integrated approach to liver disease assessment. But does combining EUS-guided biopsy, portal pressure measurement, and variceal evaluation in one session represent meaningful progress or premature adoption? Listen to the latest #TalkLivertoMe to find out! Now on EASL Campus: easlcampus.eu/tltm/episode-1… Spotify: open.spotify.com/episode/1xz… Apple Podcasts: podcasts.apple.com/us/podcas…
7
2
12
2,475
Bavevo VIII is online @JHepatology 🙏 to my panel co-chair @docberza & panellists @JuanAbraldes @EltonDajti @mathiasjachs @VWSWong et al #LiverTwitter Time for another @EASLedu Talk Liver To Me Episode, @tom_marjot ?
It’s finally here‼️ 🎉 Baveno VIII has arrived — just in time for some good summer reading ☀️📖 Time to dive into the latest consensus on portal hypertension from @BavenoCoop Enjoy! 😉 🔗 journal-of-hepatology.eu/art…
1
12
36
3,131
Tom Marjot retweeted
🔥Now available! 🔥 Endohepatology: added value or added complexity? A #TalkLiverToMe podcast discussion in 5 parts: 1⃣EUS-guided liver biopsy 2⃣EUS-guided PPG measurement 3⃣New approaches to managing gastric varices 4⃣A one-stop shop for endoscopic liver assessment? 5⃣Where is the field is heading next? @Tom_Marjot @JuanAbraldes @ESGE_news #LiverX #Endohepatology
Endohepatology promises a more integrated approach to liver disease assessment. But does combining EUS-guided biopsy, portal pressure measurement, and variceal evaluation in one session represent meaningful progress or premature adoption? Listen to the latest #TalkLivertoMe to find out! Now on EASL Campus: easlcampus.eu/tltm/episode-1… Spotify: open.spotify.com/episode/1xz… Apple Podcasts: podcasts.apple.com/us/podcas…
3
8
1,282
Tom Marjot retweeted
Endohepatology could bring biopsy, portal pressure measurement, and variceal evaluation together in a single session but where does it fit in an era of non-invasive testing? Tune in this Wednesday to #TalkLivertoMe for a discussion on evidence, clinical utility, and real-world feasibility. Read more: easl.eu/event/endohepatology…
4
7
958
Tom Marjot retweeted
There is no instruction manual for becoming an independent researcher… or is there? 👀 In this episode of #TalkLiverToMe, we unpack the skills formal training often overlooks: 🔬 Building a research programme 👥 Leading a team 💰 Securing funding 📈 Creating a sustainable academic career Available on: 🎙️Spotify open.spotify.com/show/66qmM3… 🎙️Apple Podcasts podcasts.apple.com/us/podcas… 📺EASL Campus easlcampus.eu/tltm/episode-1… @C_V_Schneider @CancerInflam @RautouE @Mandorf1 @IsraelsenMads @ZanettoAlberto @tom_marjot @FrancqueSven #LiverX
2
6
686
Tom Marjot retweeted
You’re trained to do research, but who teaches you how to run a research group? 🤔 This episode of #TalkLivertoMe looks at the practical realities of early research independence, from managing people and funding pressures to building a sustainable academic career. Listen now on EASL Campus: easlcampus.eu/tltm/episode-1… Available on Spotify: open.spotify.com/episode/1P0… and Apple Podcasts: podcasts.apple.com/fr/podcas…
2
5
11
892
Tom Marjot retweeted
What should every hepatologist know about hepatitis E?🤔 In this epsiode of #TalkLiverToMe, experts from Europe and Asia take a practical look at #HEV and discuss: ✅ Essential HEV facts ✅ Acute HEV: diagnosis and management ✅ Chronic HEV: diagnosis and management ✅ Complex clinical scenarios 🎙️Spotify open.spotify.com/episode/67J… 🎙️Apple Podcasts podcasts.apple.com/us/podcas… 📺EASL Campus easlcampus.eu/tltm/episode-1… @tom_marjot @sid8998 @GlobalHep @Hep_Alliance #LiverX #WorlHepatitisDay
Who should be tested for hepatitis E? When should treatment be considered? And how should chronic infection be managed in immunosuppressed patients? In the latest #TalkLiverToMe, experts bring perspectives from Europe and Asia to discuss practical approaches to acute and chronic hepatitis E. Listen on EASL Campus: easlcampus.eu/tltm/episode-1… Apple Podcasts: podcasts.apple.com/us/podcas… Spotify: open.spotify.com/episode/67J…
5
6
947
Tom Marjot retweeted
Who should be tested for hepatitis E? When should treatment be considered? And how should chronic infection be managed in immunosuppressed patients? In the latest #TalkLiverToMe, experts bring perspectives from Europe and Asia to discuss practical approaches to acute and chronic hepatitis E. Listen on EASL Campus: easlcampus.eu/tltm/episode-1… Apple Podcasts: podcasts.apple.com/us/podcas… Spotify: open.spotify.com/episode/67J…
10
1
12
1,982
Tom Marjot retweeted
Acute, chronic and everything in between… all you need to know about hepatitis E, coming soon to a streaming platform near you! 👀 More info in the post below👇 @tom_marjot @sid8998 @GlobalHep @Hep_Alliance #TalkLiverToMe #HEV #LiverX
Hepatitis E is not the same everywhere. In this week's episode of #TalkLiverToMe, experts from Europe and Asia share practical perspectives on who to test, when to treat, and how to manage acute and chronic hepatitis E. Out this Wednesday on EASL Campus, Spotify and Apple Podcasts! More info: easl.eu/event/global-updates…
3
4
681
Tom Marjot retweeted
Hepatitis E is not the same everywhere. In this week's episode of #TalkLiverToMe, experts from Europe and Asia share practical perspectives on who to test, when to treat, and how to manage acute and chronic hepatitis E. Out this Wednesday on EASL Campus, Spotify and Apple Podcasts! More info: easl.eu/event/global-updates…
5
1
8
1,556
Tom Marjot retweeted
MASLD is not just a liver disease and HFpEF is not just a cardiology challenge. In this week's episode of Talk Liver to Me, experts explore how these conditions overlap, why HFpEF can be missed in MASLD, and whether cardio-hepatology collaboration could improve patient care. Out this Wednesday on your favorite podcast platform! Read more: easl.eu/event/masld-and-hfpe…
1
5
1
12
3,426
Tom Marjot retweeted
New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/art… 📺easlcampus.eu/tltm/episode-1… 🎙️open.spotify.com/episode/524… 🎙️podcasts.apple.com/us/podcas… @JHepatology #LiverX
New Talk Liver to Me podcast coming up this Wednesday! 🐭 Can a mouse truly model human steatotic liver disease? And does the perfect preclinical model even exist? In the upcoming episode, we will explore the new EASL position paper on preclinical SLD models with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they will discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data. 👉 Read more easl.eu/event/chasing-the-pe… 📰 Access the position paper that will be discussed! pubmed.ncbi.nlm.nih.gov/4219… @GallageSuchira @CancerInflam @RuiCastroHD
2
1
3
1,950
This is just superlative in so many ways. Another great episode of #Talklivertome I learned so much! Please do download.
🎧 New EASL #TalkLiverToMe podcast Haemochromatosis: Who Needs Testing & Who Needs Treatment? We discuss: 🩸 Iron profiles 🩸 Genotypes 🩸 Penetrance 🩸 Fibrosis staging 🩸 Ferritin targets 🩸 Arthropathy 🎧 Apple: apple.co/4unlnfJ 🎧 Spotify: bit.ly/43ZAhy4
2
1
14
1,150